Naturally Occurring Antibodies That Recognize Linear Epitopes in the Amino Terminus of the Hepatitis C Virus E2 Protein Confer Noninterfering, Additive Neutralization

被引:55
作者
Tarr, Alexander W. [1 ,2 ]
Urbanowicz, Richard A. [1 ,2 ]
Jayaraj, Dhanya [1 ,2 ]
Brown, Richard J. P. [1 ,2 ]
McKeating, Jane A. [3 ]
Irving, William L. [1 ,2 ]
Ball, Jonathan K. [1 ,2 ]
机构
[1] Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Nottingham NG7 2RD, England
[2] Univ Nottingham, Queens Med Ctr, Nottingham Digest Dis Ctr, Biomed Res Unit, Nottingham NG7 2RD, England
[3] Univ Birmingham, Inst Biomed Res, Birmingham, W Midlands, England
基金
英国医学研究理事会;
关键词
LIVER-TRANSPLANT RECIPIENTS; HUMAN MONOCLONAL-ANTIBODIES; SCAVENGER RECEPTOR BI; TO-CELL TRANSMISSION; ENVELOPE GLYCOPROTEIN; CD81; BINDING; CHRONIC INFECTION; VIRAL ENTRY; GENOTYPES; PARTICLES;
D O I
10.1128/JVI.06492-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Chronic hepatitis C virus (HCV) infection can persist even in the presence of a broadly neutralizing antibody response. Various mechanisms that underpin viral persistence have been proposed, and one of the most recently proposed mechanisms is the presence of interfering antibodies that negate neutralizing responses. Specifically, it has been proposed that antibodies targeting broadly neutralizing epitopes located within a region of E2 encompassing residues 412 to 423 can be inhibited by nonneutralizing antibodies binding to a less conserved region encompassing residues 434 to 446. To investigate this phenomenon, we characterized the neutralizing and inhibitory effects of human-derived affinity-purified immunoglobulin fractions and murine monoclonal antibodies and show that antibodies to both regions neutralize HCV pseudoparticle (HCVpp) and cell culture-infectious virus (HCVcc) infection albeit with different breadths and potencies. Epitope mapping revealed the presence of overlapping but distinct epitopes in both regions, which may explain the observed differences in neutralizing phenotypes. Crucially, we failed to demonstrate any inhibition between these two groups of antibodies, suggesting that interference by nonneutralizing antibodies, at least for the region encompassing residues 434 to 446, does not provide a mechanism for HCV persistence in chronically infected individuals.
引用
收藏
页码:2739 / 2749
页数:11
相关论文
共 69 条
  • [1] THE NATURAL-HISTORY OF COMMUNITY-ACQUIRED HEPATITIS-C IN THE UNITED-STATES
    ALTER, MJ
    MARGOLIS, HS
    KRAWCZYNSKI, K
    JUDSON, FN
    MARES, A
    ALEXANDER, WJ
    HU, PY
    MILLER, JK
    GERBER, MA
    SAMPLINER, RE
    MEEKS, EL
    BEACH, MJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (27) : 1899 - 1905
  • [2] Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes
    Barth, H
    Cerino, R
    Arcuri, M
    Hoffmann, M
    Schürmann, P
    Adah, MI
    Gissler, B
    Zhao, XP
    Ghisetti, V
    Lavezzo, B
    Blum, HE
    von Weizsäcker, F
    Vitelli, A
    Scarselli, E
    Baumert, TF
    [J]. JOURNAL OF VIROLOGY, 2005, 79 (09) : 5774 - 5785
  • [3] Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor
    Bartosch, B
    Vitelli, A
    Granier, C
    Goujon, C
    Dubuisson, J
    Pascale, S
    Scarselli, E
    Cortese, R
    Nicosia, A
    Cosset, FL
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (43) : 41624 - 41630
  • [4] In vitro assay for neutralizing antibody to hepatitis C virus:: Evidence for broadly conserved neutralization epitopes
    Bartosch, B
    Bukh, J
    Meunier, JC
    Granier, C
    Engle, RE
    Blackwelder, WC
    Emerson, SU
    Cosset, FL
    Purcell, RH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) : 14199 - 14204
  • [5] Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes
    Bartosch, B
    Dubuisson, J
    Cosset, FL
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (05) : 633 - 642
  • [6] Neutralizing Antibody-Resistant Hepatitis C Virus Cell-to-Cell Transmission
    Brimacombe, Claire L.
    Grove, Joe
    Meredith, Luke W.
    Hu, Ke
    Syder, Andrew J.
    Flores, Maria Victoria
    Timpe, Jennifer M.
    Krieger, Sophie E.
    Baumert, Thomas F.
    Tellinghuisen, Timothy L.
    Wong-Staal, Flossie
    Balfe, Peter
    McKeating, Jane A.
    [J]. JOURNAL OF VIROLOGY, 2011, 85 (01) : 596 - 605
  • [7] GENETIC-HETEROGENEITY OF HEPATITIS-C VIRUS - QUASI-SPECIES AND GENOTYPES
    BUKH, J
    MILLER, RH
    PURCELL, RH
    [J]. SEMINARS IN LIVER DISEASE, 1995, 15 (01) : 41 - 63
  • [8] Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles
    Clayton, RF
    Owsianka, A
    Aitken, J
    Graham, S
    Bhella, D
    Patel, AH
    [J]. JOURNAL OF VIROLOGY, 2002, 76 (15) : 7672 - 7682
  • [9] A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients
    Davis, GL
    Nelson, DR
    Terrault, N
    Pruett, TL
    Schiano, TD
    Fletcher, CV
    Sapan, CV
    Riser, LN
    Li, YF
    Whitley, RJ
    Gnann, JW
    [J]. LIVER TRANSPLANTATION, 2005, 11 (08) : 941 - 949
  • [10] STRUCTURAL AND IMMUNOLOGICAL CHARACTERIZATION OF A LINEAR VIRUS-NEUTRALIZING EPITOPE OF THE RABIES VIRUS GLYCOPROTEIN AND ITS POSSIBLE USE IN A SYNTHETIC VACCINE
    DIETZSCHOLD, B
    GORE, M
    MARCHADIER, D
    NIU, HS
    BUNSCHOTEN, HM
    OTVOS, L
    WUNNER, WH
    ERTL, HCJ
    OSTERHAUS, ADME
    KOPROWSKI, H
    [J]. JOURNAL OF VIROLOGY, 1990, 64 (08) : 3804 - 3809